Susan Groenwald
CIK 1505374 · View on SEC EDGAR ↗
First SEC filing: Nov. 6, 2015 · Latest: Nov. 6, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2018 | CVSA | S | 38,695 | $45.25 | $1,750,949 | 34,402 Direct | -52.94% | Disposed | 182.5% (price as of 2026-08-21) |
| Aug. 25, 2017 | CVSA | S 10b5-1 | 5,887 | $33.80 | $198,981 | 30,582 Direct | -16.14% | Disposed | 278.1% (price as of 2026-08-21) |
| Aug. 22, 2016 | CVSA | S 10b5-1 | 13,600 | $25.48 | $346,528 | 19,603 Direct | -40.96% | Disposed | 401.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 9, 2018 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (5,318) | $23.78 | Aug. 25, 2026 | 5,318 | Disposed |
| Feb. 9, 2018 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (9,650) | $26.23 | Aug. 26, 2025 | 9,650 | Disposed |
| Feb. 9, 2018 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (12,084) | $28.32 | Aug. 21, 2023 | 12,084 | Disposed |
| Feb. 9, 2018 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (11,643) | $18.60 | Aug. 29, 2022 | 11,643 | Disposed |
| Feb. 9, 2018 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (4,316) | $28.32 | Aug. 21, 2023 | 4,316 | Disposed |
| Feb. 9, 2018 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (5,082) | $18.60 | Aug. 29, 2022 | 5,082 | Disposed |
| Aug. 23, 2017 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (12,726) | $33.90 | Aug. 23, 2027 | 12,726 | Acquired |
| Aug. 23, 2017 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (2,949) | $33.90 | Aug. 23, 2027 | 2,949 | Acquired |
| Aug. 25, 2016 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (17,070) | $23.78 | Aug. 25, 2026 | 17,070 | Acquired |
| Aug. 25, 2016 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (4,205) | $23.78 | Aug. 25, 2026 | 4,205 | Acquired |
| Aug. 26, 2015 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (15,488) | $26.23 | Aug. 26, 2025 | 15,488 | Acquired |
| Aug. 26, 2015 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (3,812) | $26.23 | Aug. 26, 2025 | 3,812 | Acquired |
| Nov. 6, 2014 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (1,000) | $34.53 | Aug. 31, 2017 | 1,000 | Disposed |
| Aug. 29, 2014 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (900) | $21.62 | Oct. 3, 2016 | 900 | Disposed |
| Aug. 29, 2014 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (2,000) | $19.45 | Jan. 3, 2016 | 2,000 | Disposed |
| Aug. 20, 2014 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (8,850) | $43.47 | Aug. 20, 2024 | 8,850 | Acquired |
| Aug. 20, 2014 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (2,300) | $43.47 | Aug. 20, 2014 | 2,300 | Acquired |
| Aug. 21, 2013 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (4,316) | $28.32 | Aug. 21, 2023 | 4,316 | Acquired |
| Aug. 21, 2013 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (12,084) | $28.32 | Aug. 21, 2023 | 12,084 | Acquired |
| Aug. 29, 2012 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (11,643) | $18.60 | Aug. 29, 2022 | 11,643 | Acquired |
| Aug. 29, 2012 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (5,082) | $18.60 | Aug. 29, 2022 | 5,082 | Acquired |
| Aug. 24, 2011 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (2,723) | $41.87 | Aug. 24, 2021 | 2,723 | Acquired |
| Aug. 24, 2011 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (5,227) | $41.87 | Aug. 24, 2021 | 5,227 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 9 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 6, 2015 | CVSA | Common Stock [F1] | — | Direct |
| Nov. 15, 2010 | CVSA | Common Stock [F1] | 1,760 | Direct |
| Nov. 15, 2010 | CVSA | Incentive Stock Option (right to buy)→ Common Stock (2,000) | 2,000 | Direct |
| Nov. 15, 2010 | CVSA | Incentive Stock Option (right to buy)→ Common Stock (900) | 900 | Direct |
| Nov. 15, 2010 | CVSA | Incentive Stock Option (right to buy)→ Common Stock (2,000) | 2,000 | Direct |
| Nov. 15, 2010 | CVSA | Incentive Stock Option (right to buy)→ Common Stock (4,433) | 4,433 | Direct |
| Nov. 15, 2010 | CVSA | Incentive Stock Option (right to buy)→ Common Stock (1,525) | 1,525 | Direct |
| Nov. 15, 2010 | CVSA | Incentive Stock Option (right to buy)→ Common Stock (2,500) | 2,500 | Direct |
| Nov. 15, 2010 | CVSA | Non-Qualified Stock Option (right to buy)→ Common Stock (2,717) | 2,717 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $443,938 | — | $315,270 | — | $288,583 | — | $57,049 | $1,334,165 |
| 2017 | $433,800 | — | — | — | $287,831 | — | — | $1,267,854 |
| 2015 | $409,231 | — | — | — | $256,894 | — | $55,651 | $1,320,850 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.